Citation: E. Kebebew et al., Localization and reoperation results for persistent and recurrent parathyroid carcinoma, ARCH SURG, 136(8), 2001, pp. 878-883
Citation: E. Kebebew et al., Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: Surgical decision analysis of a controversy using amathematical model, WORLD J SUR, 24(11), 2000, pp. 1295-1302
Authors:
Kebebew, E
Treseler, PA
Duh, QY
Clark, OH
Citation: E. Kebebew et al., The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer, SURGERY, 128(6), 2000, pp. 952-957
Citation: E. Kebebew et al., Medullary thyroid carcinoma - Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems, CANCER, 88(5), 2000, pp. 1139-1148
Citation: E. Kebebew et al., Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer, ARCH SURG, 135(8), 2000, pp. 895-899
Authors:
Kebebew, E
Tresler, PA
Siperstein, AE
Duh, QY
Clark, OH
Citation: E. Kebebew et al., Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: A report of three cases and review of the literature, THYROID, 9(2), 1999, pp. 127-131
Citation: E. Kebebew et al., Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function, J CLIN END, 84(8), 1999, pp. 2840-2847